Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: A methylation-specific polymerase chain reaction study using two different primer sets

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 73-79

  Park, Geon ^a   Kang, Seong Ho ^b   Lee, Jae Hoon ^c   Suh, Cheolwon ^d   Kim, Miyoung ^e   Park, Seung Man ^e   Kim, Tae Young ^f   Oh, Bora ^f   Min, Hyun Jung ^g   Yoon, Sung Soo ^e   Yang, In Chul ^h   Cho, Han Ik ^e,i   Lee, Dong Soon ^e,f  

^a Chosun University College of Medicine   (South Korea)

^b Green Cross Reference Laboratory   (South Korea)

^c Cachon University Gil Hospital   (South Korea)

^d Asan Medical Center   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Dow Biomedica Inc   (South Korea)

^h Korea Research Institute of Standards and Science   (South Korea)

ⁱ Korean Association of Healthy Promotion   (South Korea)

Author keywords

Methylation; Myeloma; P16; Prognosis

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; MELPHALAN; PREDNISOLONE; PROTEIN P16; THALIDOMIDE; VINCRISTINE;

ADULT; ADVERSE OUTCOME; AGE; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHROMOSOME DELETION 17P; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; DNA METHYLATION; FEMALE; GENDER; GENE TRANSLOCATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL STAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MULTIPLE MYELOMA; OVERALL SURVIVAL; PLASMA CELL; PLASMA CELL IN BONE MARROW; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN BLOOD LEVEL; SOUTH KOREA; SURVIVAL TIME;

EID: 85027921379     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1043-9     Document Type: Article

References (31)

1. M Gonzalez-Zulueta CM Bender AS Yang, et al. 1995 Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Res 55 4531 4535 1:CAS:528:DyaK2MXoslWmsrY%3D 7553622
2. A Merlo JG Herman L Mao, et al. 1995 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 686 692 1:CAS:528:DyaK2MXms1Kgtr4%3D 10.1038/nm0795-686 7585152
3. PL Jones AP Wolffe 1999 Relationships between chromatin organization and DNA methylation in determining gene expression Semin Cancer Biol 9 339 347 1:CAS:528:DyaK1MXntVagsrw%3D 10.1006/scbi.1999.0134 10547342 (Pubitemid 29532860)
4. SU Kass D Pruss AP Wolffe 1997 How does DNA methylation repress transcription? Trends Genet 13 444 449 1:CAS:528:DyaK2sXnsValsbw%3D 10.1016/S0168-9525(97)01268-7 9385841 (Pubitemid 27479903)
5. O Galm S Wilop J Reichelt, et al. 2004 DNA methylation changes in multiple myeloma Leukemia 18 1687 1692 1:CAS:528:DC%2BD2cXnvV2qsL0%3D 10.1038/sj.leu.2403434 15318245 (Pubitemid 39386348)
6. G Guillerm S Depil D Wolowiec B Quesnel 2003 Different prognostic values of p15(INK4b) and p16(INK4a) gene methylations in multiple myeloma Haematologica 88 476 478 12681979
7. S Seidl J Ackermann H Kaufmann, et al. 2004 DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies Cancer 100 2598 2606 1:CAS:528: DC%2BD2cXlsFChs70%3D 10.1002/cncr.20295 15197802 (Pubitemid 38715765)
8. T Uchida T Kinoshita T Ohno H Ohashi H Nagai H Saito 2001 Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia Leukemia 15 157 165 1:CAS:528:DC%2BD3MXhtlaltbg%3D 10.1038/sj.leu.2401991 11243384 (Pubitemid 32124080)
9. CS Cim TK Fung R Liang 2003 Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS Leukemia 17 2533 2535 10.1038/sj.leu.2403133 (Pubitemid 38072597)
10. CS Chim R Liang MH Leung, et al. 2006 Aberrant gene promoter methylation marking disease progression in multiple myeloma Leukemia 20 1190 1192 1:CAS:528:DC%2BD28XkvVymtbc%3D 10.1038/sj.leu.2404205 16598307 (Pubitemid 43797324)
11. O Furonaka Y Takeshima H Awaya H Ishida N Kohno K Inai 2004 Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma Pathol Int 54 8 549 555 1:CAS:528:DC%2BD2cXnslSksL4%3D 10.1111/j.1440-1827.2004.01663.x 15260845 (Pubitemid 39149845)
12. EP Xing Y Nie Y Song GY Yang YC Cai LD Wang CS Yang 1999 Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma Clin Cancer Res 5 2704 2713 1:CAS:528:DyaK1MXntlGltLk%3D 10537333
13. N Gonzalez-Paz WJ Chng RF McClure, et al. 2007 Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications Blood 109 1228 1232 1:CAS:528:DC%2BD2sXjtFertb8%3D 10.1182/blood-2006-05-024661 16840723 (Pubitemid 46220672)
14. MV Mateos R Garcia-Sanz R Lopez-Perez, et al. 2002 Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with hIgH plasma cell proliferation and short survival Br J Haematol 118 1034 1040 1:CAS:528:DC%2BD38Xotlanurg%3D 10.1046/j.1365-2141.2002.03749.x 12199782 (Pubitemid 35025966)
15. J San-Miguel R Garcia-Sanz R Lopez-Perez 2005 Analysis of methylation pattern in multiple myeloma Acta Haematol 114 Suppl 1 23 26 1:CAS:528: DC%2BD2MXhtVWntr7O 10.1159/000087041 16166769 (Pubitemid 41318167)
16. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826 1:CAS:528:DyaK28XlsFeht7Y%3D 10.1073/pnas.93.18.9821 8790415 (Pubitemid 26296693)
17. A Dib B Barlogie JD Shaughnessy Jr. WM Kuehl 2007 Methylation and expression of the p16INK4A tumor suppressor gene in multiple myeloma Blood 109 1337 1338 1:CAS:528:DC%2BD2sXjtFeru78%3D 10.1182/blood-2006-09-049510 17244692 (Pubitemid 46220692)
18. M Gonzalez MV Mateos R Garcia-Sanz, et al. 2000 De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis Leukemia 14 183 187 1:CAS:528:DC%2BD3cXhtV2ntbw%3D 10.1038/sj.leu.2401617 10637494
19. MV Mateos M Gonzalez A Balanzategui, et al. 2000 Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection Clin Biochem 33 415 418 10.1016/S0009-9120(00)00143-0 11018695
20. C Ribas GW Colleoni RS Felix, et al. 2005 p16 gene methylation lacks correlation with angiogenesis and prognosis in multiple myeloma Cancer Lett 222 247 254 1:CAS:528:DC%2BD2MXjs1GhsLo%3D 10.1016/j.canlet.2004.09.038 15863274 (Pubitemid 40603652)
21. PG Richardson B Barlogie J Berenson, et al. 2003 A phase 2 study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2609 2617 1:CAS:528:DC%2BD3sXkvVSksLs%3D 10.1056/NEJMoa030288 12826635 (Pubitemid 36741588)
22. B Barlogie L Smith R Alexanian 1984 Effective treatment of advanced multiple myeloma refractory to alkylating agents N Engl J Med 310 1353 1356 1:STN:280:DyaL2c7ptFemtg%3D%3D 10.1056/NEJM198405243102104 6546971
23. SV Rajkumar S Hayman MA Gertz, et al. 2002 Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma J Clin Oncol 20 4319 4323 1:CAS:528:DC%2BD38Xpt1CjtLk%3D 10.1200/JCO.2002.02.116 12409330 (Pubitemid 35266292)
24. A Palumbo A Bertola P Falco, et al. 2004 Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma Hematol J 5 318 324 1:CAS:528:DC%2BD2cXmtlSjurY%3D 10.1038/sj.thj.6200403 15297848 (Pubitemid 39214209)
25. R Aplenc E Orudjev J Swoyer B Manke T Rebbeck 2002 Differential bone marrow aspirate DNA yields from commercial extraction kits Leukemia 16 1865 1866 1:CAS:528:DC%2BD38XmsV2lt7Y%3D 10.1038/sj.leu.2402681 12200706
26. Czepulkowski B (2001) Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In: Rooney DE (ed) Human cytogenetics: malignancy and acquired abnormalities, 3rd edn. Oxford University Press, Oxford, pp 1-26
27. Shaffer LG, Tommerup N (eds) (2005) ISCN 2005: an international system for human cytogenetic nomenclature. S. Karger, Basel
28. PR Greipp J San Miguel BG Durie, et al. 2005 International staging system for multiple myeloma J Clin Oncol 23 3412 3420 10.1200/JCO.2005.04.242 15809451
29. J Silva JM Silva G Dominguez, et al. 2003 Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms J Pathol 199 289 297 1:CAS:528:DC%2BD3sXis1ektbc%3D 10.1002/path.1297 12579530 (Pubitemid 36266851)
30. J Tost IG Gut 2007 DNA methylation analysis by pyrosequencing Nat Protoc 2 2265 2275 1:CAS:528:DC%2BD2sXhtFagsb7J 10.1038/nprot.2007.314 17853883 (Pubitemid 351575045)
31. F Wilborn CA Schmidt W Siegert 1993 Demonstration of chimerism after allogeneic bone marrow transplantation by polymerase chain reaction of Y-chromosome-specific nucleotide sequences-characterization of a new technical approach Leukemia 7 140 143 1:STN:280:DyaK3s7hs1Clsw%3D%3D 8418373